Cargando…

Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations

Bone morphogenetic proteins (BMPs) are growth factors that have a vital role in the production of bone, cartilage, ligaments, and tendons. Tumors’ upregulation of bone morphogenetic proteins (BMPs) and their receptors are key features of cancer progression. Regulation of the BMP kinase system is a n...

Descripción completa

Detalles Bibliográficos
Autores principales: Belal, Amany, Elkady, Hazem, Al-Karmalawy, Ahmed A., Amin, Ali H., Ghoneim, Mohammed M., El-Sherbiny, Mohamed, Al-Serwi, Rasha Hamed, Abdou, Mohamed Attia, Ibrahim, Mona H., Mehany, Ahmed B. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457949/
https://www.ncbi.nlm.nih.gov/pubmed/36080338
http://dx.doi.org/10.3390/molecules27175571
_version_ 1784786181818417152
author Belal, Amany
Elkady, Hazem
Al-Karmalawy, Ahmed A.
Amin, Ali H.
Ghoneim, Mohammed M.
El-Sherbiny, Mohamed
Al-Serwi, Rasha Hamed
Abdou, Mohamed Attia
Ibrahim, Mona H.
Mehany, Ahmed B. M.
author_facet Belal, Amany
Elkady, Hazem
Al-Karmalawy, Ahmed A.
Amin, Ali H.
Ghoneim, Mohammed M.
El-Sherbiny, Mohamed
Al-Serwi, Rasha Hamed
Abdou, Mohamed Attia
Ibrahim, Mona H.
Mehany, Ahmed B. M.
author_sort Belal, Amany
collection PubMed
description Bone morphogenetic proteins (BMPs) are growth factors that have a vital role in the production of bone, cartilage, ligaments, and tendons. Tumors’ upregulation of bone morphogenetic proteins (BMPs) and their receptors are key features of cancer progression. Regulation of the BMP kinase system is a new promising strategy for the development of anti-cancer drugs. In this work, based on a careful literature study, a library of benzothiophene and benzofuran derivatives was subjected to different computational techniques to study the effect of chemical structure changes on the ability of these two scaffolds to target BMP-2 inducible kinase, and to reach promising candidates with proposed activity against BMP-2 inducible kinase. The results of screening against Lipinski’s and Veber’s Rules produced twenty-one outside eighty-four compounds having drug-like molecular nature. Computational ADMET studies favored ten compounds (11, 26, 27, 29, 30, 31, 34, 35, 65, and 72) with good pharmacokinetic profile. Computational toxicity studies excluded compound 34 to elect nine compounds for molecular docking studies which displayed eight compounds (26, 27, 29, 30, 31, 35, 65, and 72) as promising BMP-2 inducible kinase inhibitors. The nine fascinating compounds will be subjected to extensive screening against serine/threonine kinases to explore their potential against these critical proteins. These promising candidates based on benzothiophene and benzofuran scaffolds deserve further clinical investigation as BMP-2 kinase inhibitors for the treatment of cancer.
format Online
Article
Text
id pubmed-9457949
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94579492022-09-09 Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations Belal, Amany Elkady, Hazem Al-Karmalawy, Ahmed A. Amin, Ali H. Ghoneim, Mohammed M. El-Sherbiny, Mohamed Al-Serwi, Rasha Hamed Abdou, Mohamed Attia Ibrahim, Mona H. Mehany, Ahmed B. M. Molecules Article Bone morphogenetic proteins (BMPs) are growth factors that have a vital role in the production of bone, cartilage, ligaments, and tendons. Tumors’ upregulation of bone morphogenetic proteins (BMPs) and their receptors are key features of cancer progression. Regulation of the BMP kinase system is a new promising strategy for the development of anti-cancer drugs. In this work, based on a careful literature study, a library of benzothiophene and benzofuran derivatives was subjected to different computational techniques to study the effect of chemical structure changes on the ability of these two scaffolds to target BMP-2 inducible kinase, and to reach promising candidates with proposed activity against BMP-2 inducible kinase. The results of screening against Lipinski’s and Veber’s Rules produced twenty-one outside eighty-four compounds having drug-like molecular nature. Computational ADMET studies favored ten compounds (11, 26, 27, 29, 30, 31, 34, 35, 65, and 72) with good pharmacokinetic profile. Computational toxicity studies excluded compound 34 to elect nine compounds for molecular docking studies which displayed eight compounds (26, 27, 29, 30, 31, 35, 65, and 72) as promising BMP-2 inducible kinase inhibitors. The nine fascinating compounds will be subjected to extensive screening against serine/threonine kinases to explore their potential against these critical proteins. These promising candidates based on benzothiophene and benzofuran scaffolds deserve further clinical investigation as BMP-2 kinase inhibitors for the treatment of cancer. MDPI 2022-08-30 /pmc/articles/PMC9457949/ /pubmed/36080338 http://dx.doi.org/10.3390/molecules27175571 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Belal, Amany
Elkady, Hazem
Al-Karmalawy, Ahmed A.
Amin, Ali H.
Ghoneim, Mohammed M.
El-Sherbiny, Mohamed
Al-Serwi, Rasha Hamed
Abdou, Mohamed Attia
Ibrahim, Mona H.
Mehany, Ahmed B. M.
Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title_full Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title_fullStr Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title_full_unstemmed Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title_short Discovery of Some Heterocyclic Molecules as Bone Morphogenetic Protein 2 (BMP-2)-Inducible Kinase Inhibitors: Virtual Screening, ADME Properties, and Molecular Docking Simulations
title_sort discovery of some heterocyclic molecules as bone morphogenetic protein 2 (bmp-2)-inducible kinase inhibitors: virtual screening, adme properties, and molecular docking simulations
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9457949/
https://www.ncbi.nlm.nih.gov/pubmed/36080338
http://dx.doi.org/10.3390/molecules27175571
work_keys_str_mv AT belalamany discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT elkadyhazem discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT alkarmalawyahmeda discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT aminalih discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT ghoneimmohammedm discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT elsherbinymohamed discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT alserwirashahamed discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT abdoumohamedattia discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT ibrahimmonah discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations
AT mehanyahmedbm discoveryofsomeheterocyclicmoleculesasbonemorphogeneticprotein2bmp2induciblekinaseinhibitorsvirtualscreeningadmepropertiesandmoleculardockingsimulations